These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8676909)

  • 1. The micronucleus test and NTP rodent carcinogens: not so many false negatives.
    Galloway SM
    Mutat Res; 1996 Jun; 352(1-2):185-8. PubMed ID: 8676909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rodent bone marrow micronucleus assay: contrast between its sensitivity to human carcinogens and its insensitivity to NTP rodent carcinogens.
    Ashby J; Tinwell H
    Mutat Res; 1996 Jun; 352(1-2):181-4. PubMed ID: 8676908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.
    Rothfuss A; O'Donovan M; De Boeck M; Brault D; Czich A; Custer L; Hamada S; Plappert-Helbig U; Hayashi M; Howe J; Kraynak AR; van der Leede BJ; Nakajima M; Priestley C; Thybaud V; Saigo K; Sawant S; Shi J; Storer R; Struwe M; Vock E; Galloway S
    Mutat Res; 2010 Sep; 702(1):40-69. PubMed ID: 20656055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
    Kirkland D; Speit G
    Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
    Brambilla G; Martelli A
    Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronucleated erythrocyte frequency in peripheral blood of B6C3F(1) mice from short-term, prechronic, and chronic studies of the NTP carcinogenesis bioassay program.
    Witt KL; Knapton A; Wehr CM; Hook GJ; Mirsalis J; Shelby MD; MacGregor JT
    Environ Mol Mutagen; 2000; 36(3):163-94. PubMed ID: 11044899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further analysis of Ames-negative rodent carcinogens that are only genotoxic in mammalian cells in vitro at concentrations exceeding 1 mM, including retesting of compounds of concern.
    Kirkland D; Fowler P
    Mutagenesis; 2010 Nov; 25(6):539-53. PubMed ID: 20720197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of human carcinogens and NTP rodent carcinogens in the mouse bone marrow micronucleus assay: an integrative approach to genetic toxicity data assessment.
    Tinwell H; Ashby J
    Environ Health Perspect; 1994 Sep; 102(9):758-62. PubMed ID: 9657707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a repeated-dose liver micronucleus assay using adult rats (II): further investigation of 1,2-dimethylhydrazine and 2,6-diaminotoluene.
    Takasawa H; Takashima R; Hattori A; Narumi K; Kawasako K; Morita T; Hayashi M; Hamada S
    Mutat Res; 2013 Feb; 751(1):12-8. PubMed ID: 23123978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type.
    Fowler P; Smith K; Young J; Jeffrey L; Kirkland D; Pfuhler S; Carmichael P
    Mutat Res; 2012 Feb; 742(1-2):11-25. PubMed ID: 22138618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of the rodent carcinogens thioacetamide and acetamide in the mouse bone marrow micronucleus assay.
    Mirkova ET
    Mutat Res; 1996 Jun; 352(1-2):23-30. PubMed ID: 8676911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a liver micronucleus assay in young rats (III): a study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS).
    Takasawa H; Suzuki H; Ogawa I; Shimada Y; Kobayashi K; Terashima Y; Matsumoto H; Aruga C; Oshida K; Ohta R; Imamura T; Miyazaki A; Kawabata M; Minowa S; Hayashi M
    Mutat Res; 2010 Apr; 698(1-2):30-7. PubMed ID: 20188853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring.
    Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S
    Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.